| Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ... Nature medicine 27 (8), 1410-1418, 2021 | 210 | 2021 |
| Phase I/Ib study of pembrolizumab plus vorinostat in advanced/metastatic non–small cell lung cancer JE Gray, A Saltos, T Tanvetyanon, EB Haura, B Creelan, SJ Antonia, ... Clinical Cancer Research 25 (22), 6623-6632, 2019 | 111 | 2019 |
| Proteogenomic landscape of squamous cell lung cancer PA Stewart, EA Welsh, RJC Slebos, B Fang, V Izumi, M Chambers, ... Nature communications 10 (1), 3578, 2019 | 96 | 2019 |
| Prospective single-arm phase 1 and 2 study: ipilimumab and nivolumab with thoracic radiation therapy after platinum chemotherapy in extensive-stage small cell lung cancer BA Perez, S Kim, M Wang, AM Karimi, C Powell, J Li, TJ Dilling, ... International Journal of Radiation Oncology* Biology* Physics 109 (2), 425-435, 2021 | 34 | 2021 |
| Hypoxia-related radiomics and immunotherapy response: a multicohort study of non-small cell lung cancer I Tunali, Y Tan, JE Gray, E Katsoulakis, SA Eschrich, J Saller, HJWL Aerts, ... JNCI Cancer Spectrum 5 (4), pkab048, 2021 | 27 | 2021 |
| Response to checkpoint inhibitor therapy in advanced classic Kaposi sarcoma: a case report and immunogenomic study J Saller, CM Walko, SZ Millis, E Henderson-Jackson, R Makanji, AS Brohl Journal of the National Comprehensive Cancer Network 16 (7), 797-800, 2018 | 27 | 2018 |
| Abstract CT056: Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC): A phase I trial B Creelan, C Wang, J Teer, E Toloza, J Mullinax, J Yao, J Koomen, S Kim, ... Cancer research 80 (16_Supplement), CT056-CT056, 2020 | 24 | 2020 |
| PHGDH supports liver ceramide synthesis and sustains lipid homeostasis YP Kang, A Falzone, M Liu, P González-Sánchez, BH Choi, JL Coloff, ... Cancer & metabolism 8, 1-13, 2020 | 18 | 2020 |
| A community‐based lung cancer rapid tissue donation protocol provides high‐quality drug‐resistant specimens for proteogenomic analyses TA Boyle, GP Quinn, MB Schabath, T Muñoz‐Antonia, JJ Saller, ... Cancer Medicine 9 (1), 225-237, 2020 | 13 | 2020 |
| Molecular pathology of lung cancer JJ Saller, TA Boyle Cold Spring Harbor Perspectives in Medicine, a037812, 2021 | 12 | 2021 |
| Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling … JK Hicks, J Saller, E Wang, T Boyle, JE Gray Lung Cancer 111, 135-138, 2017 | 11 | 2017 |
| Novel and Expanded Oncology Drug Approvals of 2016-PART 1: New Options in Solid Tumor Management. TC Knepper, J Saller, CM Walko Oncology (Williston Park, NY) 31 (2), 110-121, 2017 | 10 | 2017 |
| Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC). AN Saltos, T Tanvetyanon, BC Creelan, MR Shafique, SJ Antonia, ... Journal of Clinical Oncology 38 (15_suppl), 9567-9567, 2020 | 9 | 2020 |
| EGFR L861Q mutation in a metastatic solid-pseudopapillary neoplasm of the pancreas KG Neill, J Saller, S Al Diffalha, BA Centeno, MP Malafa, D Coppola Cancer Genomics & Proteomics 15 (3), 201-205, 2018 | 9 | 2018 |
| EPB41L5 is associated with the metastatic potential of low-grade pancreatic neuroendocrine tumors J Saller, S Seydafkan, M Shahid, M Gadara, M Cives, SA Eschrich, ... Cancer Genomics & Proteomics 16 (5), 309-318, 2019 | 8 | 2019 |
| Integrated proteomics-based physical and functional mapping of axl kinase signaling pathways and inhibitors define its role in cell migration A Majumder, S Hosseinian, M Stroud, E Adhikari, JJ Saller, MA Smith, ... Molecular Cancer Research 20 (4), 542-555, 2022 | 6 | 2022 |
| Cdx-2 expression in esophageal biopsies without goblet cell intestinal metaplasia may be predictive of Barrett’s esophagus J Saller, S Al Diffalha, K Neill, RA Bhaskar, C Oliveri, D Boulware, ... Digestive diseases and sciences 65, 1992-1998, 2020 | 6 | 2020 |
| FGD4 (Frabin) overexpression in pancreatic neuroendocrine neoplasms M Shahid, TB George, J Saller, M Haija, Z Sayegh, D Boulware, ... Pancreas 48 (10), 1307-1311, 2019 | 6 | 2019 |
| Hypoxia-Related radiomics predict immunotherapy response: a multi-cohort study of NSCLC I Tunali, Y Tan, JE Gray, E Katsoulakis, SA Eschrich, J Saller, T Boyle, J Qi, ... BioRxiv, 2020.04. 02.020859, 2020 | 5 | 2020 |
| A microRNA signature identifies patients at risk of barrett esophagus progression to dysplasia and cancer J Saller, K Jiang, Y Xiong, SJ Yoder, K Neill, JM Pimiento, L Pena, ... Digestive diseases and sciences, 1-8, 2022 | 4 | 2022 |
Ben Creelan, MD MSH. Lee Moffitt Cancer Center & Research InstituteVerified email at moffitt.org
